Bibliographic Details
| Title: |
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. |
| Authors: |
Waterhouse DN; Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada., Sutherland BW, Santos ND, Masin D, Osooly M, Strutt D, Ostlund C, Anantha M, Harasym N, Manisali I, Wehbe M, Bally MB, Webb MS |
| Source: |
Investigational new drugs [Invest New Drugs] 2014 Dec; Vol. 32 (6), pp. 1071-82. Date of Electronic Publication: 2014 Jul 27. |
| Publication Type: |
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
